$JNJ
Johnson & Johnson
XNYS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is JNJ down today? It is at $252.75 (-1.28%), and our scanner flagged it 53 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JNJ spikes, and full due diligence on JNJ — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JNJ 53 times in the last 30 days. Create a free account to track $JNJ, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
JNJ is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on JNJ today, peaking at 71.5x its normal volume. A recent catalyst in the news: “FDA Expands Eli Lilly's Blood Cancer Drug Label in First-Line Setting.” Early read: bearish.
Likely catalystJohnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 11, 2026 · 24 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Schmid Timothy Officer | Sold (automatic/other) | -34K | sold 57% | 25K | $9.2M at $274.74 | Sep 2, 26 |
Schmid Timothy Officer | Other | 34K | added 100% | 48K | $4.4M at $131.94 | Sep 2, 26 |
Taubert Jennifer L Officer | Sold (automatic/other) | -15K | sold 7.2% | 194K | $4.0M at $263.36 | Aug 17, 26 |
Taubert Jennifer L Officer | Other | 15K | added 7.7% | 209K | $1.7M at $115.67 | Aug 17, 26 |
Duato Joaquin Officer | Sold (automatic/other) | -123K | sold 31% | 276K | $32.2M at $261.00 | Aug 13, 26 |
Duato Joaquin Officer | Other | 123K | added 45% | 399K | $14.3M at $115.67 | Aug 13, 26 |
Forminard Elizabeth Officer | Sold (automatic/other) | -16K | sold 48% | 17K | $4.1M at $255.93 | Aug 6, 26 |
Forminard Elizabeth Officer | Other | 9K | added 40% | 33K | $1.2M at $131.94 | Aug 6, 26 |
Duato Joaquin Officer | Sold (automatic/other) | -48K | sold 15% | 276K | $12.5M at $258.06 | Aug 5, 26 |
Broadhurst Vanessa Officer | Sold (automatic/other) | -23K | sold 50% | 23K | $5.8M at $251.27 | Jul 20, 26 |
Broadhurst Vanessa Officer | Other | 23K | added 100% | 46K | $3.0M at $129.51 | Jul 20, 26 |
Wengel Kathryn E Officer | Sold (automatic/other) | -10K | sold 8.0% | 114K | $2.4M at $241.15 | Jun 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.








Comparable names in pharmaceutical preparations, closest in size first.
Curated groups JNJ belongs to. Tap one to see every member with today's move and why the group is moving.
JNJ is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on JNJ today, peaking at 71.5x its normal volume. A recent catalyst in the news: “FDA Expands Eli Lilly's Blood Cancer Drug Label in First-Line Setting.” Early read: bearish.
JNJ last traded at $252.75, down 1.28% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Johnson & Johnson (JNJ) is next expected to report earnings on Tuesday, October 13, 2026 (before open), about 8 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The JNJ Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JNJ 53 times in the last 30 days.
JNJ (Johnson & Johnson) trades on XNYS, with a market cap of about $617.01B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JNJ for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JNJ discussion
Sign in to ask a question or join the discussion.